Gut microbiota as a key regulator in endometriosis: mechanisms, therapeutic opportunities, and future perspectives
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2025.1730739 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Xiaojun Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Endometriosis, Gastrointestinal Microbiome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Endometriosis (EMs), a common and frequently occurring gynecological disease, is a major cause of chronic pelvic pain and infertility in women. Its pathogenesis remains unclear to date, and it is characterized by high invasiveness and recurrence tendency. Although the specific pathogenesis of EMs has not been clarified, existing studies have confirmed that gut microbiota dysbiosis plays an important role in its pathogenic process. Studies suggest that gut microbiota may affect the occurrence and progression of EMs through immunoinflammatory pathways and metabolic pathways (such as enhanced estrogen metabolism and abnormal lipid metabolism). Meanwhile, approaches including dietary intervention, supplementation of probiotics or prebiotics, and microbiota transplantation can help prevent and alleviate EMs symptoms, providing potential therapeutic methods. This article will review the research progress on the correlation between gut microbiota dysbiosis and EMs, with the aim of offering more references for the diagnosis and treatment of EMs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Medicine Center, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
- Department of Dermatology, Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China.
Zitieren
APA
Liu, X., Fan, M., Wang, Y., He, D., & Liu, L. (2026). Gut microbiota as a key regulator in endometriosis: mechanisms, therapeutic opportunities, and future perspectives. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1730739
Vancouver
Liu X, Fan M, Wang Y, He D, Liu L. Gut microbiota as a key regulator in endometriosis: mechanisms, therapeutic opportunities, and future perspectives. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2025.1730739
BibTeX
@article{Liu2026,
author = {Liu, Xiaojun and Fan, Minghui and Wang, Yang and He, Dongyun and Liu, Li},
title = {Gut microbiota as a key regulator in endometriosis: mechanisms, therapeutic opportunities, and future perspectives},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2025.1730739}
}
EUVIMED